Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming

An ideal malaria vaccine platform should potently induce protective immune responses and block parasite transmission from mosquito to human, and it should maintain these effects for an extended period. Here, we have focused on vaccine development based on adeno-associated virus serotype 1 (AAV1), a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Yusuf, Yenni, Yoshii, Tatsuya, Iyori, Mitsuhiro, Yoshida, Kunitaka, Mizukami, Hiroaki, Fukumoto, Shinya, Yamamoto, Daisuke S., Alam, Asrar, Emran, Talha Bin, Amelia, Fitri, Islam, Ashekul, Otsuka, Hiromu, Takashima, Eizo, Tsuboi, Takafumi, Yoshida, Shigeto
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6460511/
https://ncbi.nlm.nih.gov/pubmed/31024558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00730
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares